Legal & General Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$994K Sell
39,727
-11,756
-23% -$331K ﹤0.01% 2145
2025
Q4
$1.62M Sell
51,483
-6,708
-12% -$222K ﹤0.01% 2057
2025
Q3
$2.08M Buy
58,191
+272
+0.5% +$12.4K ﹤0.01% 1965
2025
Q2
$3.34M Buy
57,919
+5,752
+11% +$325K ﹤0.01% 1742
2025
Q1
$3.04M Buy
52,167
+2,196
+4% +$150K ﹤0.01% 1757
2024
Q4
$4.02M Buy
49,971
+1,080
+2% +$92.3K ﹤0.01% 1686
2024
Q3
$3.92M Buy
48,891
+3,839
+9% +$273K ﹤0.01% 1684
2024
Q2
$2.75M Buy
45,052
+299
+0.7% +$17.8K ﹤0.01% 1798
2024
Q1
$2.21M Buy
44,753
+1,172
+3% +$55.8K ﹤0.01% 1899
2023
Q4
$1.83M Buy
43,581
+5,114
+13% +$174K ﹤0.01% 1995
2023
Q3
$1.26M Buy
38,467
+4,611
+14% +$157K ﹤0.01% 2103
2023
Q2
$1.2M Buy
33,856
+26,796
+380% +$886K ﹤0.01% 2147
2023
Q1
$201K Buy
7,060
+217
+3% +$7.65K ﹤0.01% 2590
2022
Q4
$284K Buy
6,843
+295
+5% +$12.7K ﹤0.01% 2485
2022
Q3
$271K Sell
6,548
-2,747
-30% -$110K ﹤0.01% 2510
2022
Q2
$304K Buy
9,295
+8,585
+1,209% +$312K ﹤0.01% 2491
2022
Q1
$25K Hold
710
﹤0.01% 3178
2021
Q4
$18K Buy
+710
New +$26.3K ﹤0.01% 3311

Other funds holding PRCT